USTR Seeks Comments Regarding Foreign Nations Freeloading on American-Financed Innovation
USTR noticePublished 25/05/23Open the original
Summary
Under Executive Order 14297, USTR requests comments on foreign practices, such as suppressing pharmaceutical prices below fair market value, that force American patients to pay a disproportionate share of global drug research and development; comments are due June 27, 2025.
By industry
- Healthcare & Drug Pricing1 trading day+0.9%p15 stocks5 trading days+1.1%p15 stocks20 trading days−1.1%p15 stocks
“suppressing the price of pharmaceutical products below fair market value in foreign countries”
Day by day after the announcement
| Day | Healthcare & Drug Pricing stocks | S&P 500 |
|---|---|---|
| 25/05/22 | 0.0% | 0.0% |
| 25/05/23 | +0.1% | −0.8% |
| 25/05/27 | +1.0% | +1.4% |
| 25/05/28 | +0.4% | +2.1% |
| 25/05/29 | +1.2% | +1.1% |
| 25/05/30 | +2.1% | +1.0% |
| 25/06/02 | +2.1% | +1.7% |
| 25/06/03 | +2.0% | +2.1% |
| 25/06/04 | +1.9% | +2.1% |
| 25/06/05 | +1.7% | +1.6% |
| 25/06/06 | +2.9% | +2.8% |
| 25/06/09 | +3.0% | +2.8% |
| 25/06/10 | +3.6% | +3.3% |
| 25/06/11 | +3.9% | +3.1% |
| 25/06/12 | +5.7% | +3.4% |
| 25/06/13 | +5.4% | +2.3% |
| 25/06/16 | +4.6% | +3.3% |
| 25/06/17 | +3.3% | +2.4% |
| 25/06/18 | +3.3% | +2.5% |
| 25/06/20 | +2.7% | +2.0% |
| 25/06/23 | +2.4% | +3.5% |
Korean stocks in these industries
- Samsung Biologics 207940
- Celltrion 068270
- SK Biopharmaceuticals 326030
Trades in these industries around the announcement
Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.
- Stephen J. Hemsley
BuyUnitedhealth Group
BuyUnitedhealth Group
UNH
$25M
86,700 sh
$25M
Filed 25/05/16
Traded 25/05/16
- John F. Rex
BuyUnitedhealth Group
BuyUnitedhealth Group
UNH
$5M
17,175 sh
$5M
Filed 25/05/16
Traded 25/05/16
- Kristen Gil
BuyUnitedhealth Group
BuyUnitedhealth Group
UNH
$1M
3,700 sh
$1M
Filed 25/05/16
Traded 25/05/15
- Timothy Patrick Flynn
BuyUnitedhealth Group
BuyUnitedhealth Group
UNH
$491.8K
1,533 sh
$491.8K
Filed 25/05/16
Traded 25/05/14
- John H. Noseworthy
BuyUnitedhealth Group
BuyUnitedhealth Group
UNH
$93.6K
300 sh
$93.6K
Filed 25/05/16
Traded 25/05/14
- Samit Hirawat
BuyBristol Myers Squibb
BuyBristol Myers Squibb
BMY
$202.2K
4,250 sh
$202.2K
Filed 25/04/29
Traded 25/04/25
- Julia Letlow
Full saleUnitedhealth Group
Full saleUnitedhealth Group
UNH
$1K–$15K
Self
$1K–$15K
Reported 01/13
Traded 25/05/27
- Guy P. Sansone
BuyCVS Health
BuyCVS Health
CVS
$100K
1,570 sh
$100K
Filed 25/06/09
Traded 25/06/05
- Larry Robbins
SellCVS Health
SellCVS Health
CVS
$113.2M
1,679,736 sh
$113.2M
Filed 25/05/06
Traded 25/05/02
- Larry Robbins
SellCVS Health
SellCVS Health
CVS
$82.7M
1,226,933 sh
$82.7M
Filed 25/05/06
Traded 25/05/05
- Julia Letlow
BuyPfizer
BuyPfizer
PFE
$1K–$15K
Self
$1K–$15K
Reported 01/13
Traded 25/06/17
- Julia Letlow
BuyAbbVie
BuyAbbVie
ABBV
$1K–$15K
Self
$1K–$15K
Reported 01/13
Traded 25/04/28
- John Boozman
Full saleUnitedhealth Group
Full saleUnitedhealth Group
UNH
$1K–$15K
Joint
$1K–$15K
Reported 25/07/09
Traded 25/06/11
- Larry Robbins
SellCVS Health
SellCVS Health
CVS
$26M
373,776 sh
$26M
Filed 25/05/06
Traded 25/05/02
- Mark Kaye
SellElevance Health
SellElevance Health
ELV
$1.9M
4,588 sh
$1.9M
Filed 25/04/25
Traded 25/04/24
- Patrick Hugh Conway
SellUnitedhealth Group
SellUnitedhealth Group
UNH
$179.6K
589 sh
$179.6K
Filed 25/06/12
Traded 25/06/10
- Larry Robbins
SellCVS Health
SellCVS Health
CVS
$15.2M
222,556 sh
$15.2M
Filed 25/05/06
Traded 25/05/02
- Brian S. Tyler
Sell10b5-1 planMcKesson
Sell10b5-1 planMcKesson
MCK
$13.7M
19,370 sh
$13.7M
Filed 25/06/09
Traded 25/06/06
- Larry Robbins
SellCVS Health
SellCVS Health
CVS
$10M
150,000 sh
$10M
Filed 25/05/06
Traded 25/05/06
- Daniel Patrick O'Day
Sell10b5-1 planGilead Sciences
Sell10b5-1 planGilead Sciences
GILD
$706.5K
6,416 sh
$706.5K
Filed 25/06/02
Traded 25/05/30